11 – 20 of 95
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
HLA Class I Genotype Is Associated with Relapse Risk after Allogeneic Stem Cell Transplantation for NPM1-Mutated Acute Myeloid Leukemia
(
- Contribution to journal › Article
-
Mark
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma : 2023 Update
(
- Contribution to journal › Scientific review
-
Mark
Editorial : Biomarkers in the era of cancer immunotherapy: zooming in from the periphery to the tumor microenvironment
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
CRISPR Screens Identify Candidate Therapeutic Targets in Leukemia
2023) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
ATOR-1017 (evunzekibart), an Fc-gamma receptor conditional 4-1BB agonist designed for optimal safety and efficacy, activates exhausted T cells in combination with anti-PD-1
(
- Contribution to journal › Article
-
Mark
Examination of the Protein Drug Supply Chain in a Swedish University Hospital : Focus on Handling Risks and Mitigation Measures
(
- Contribution to journal › Article
-
Mark
Restoring antitumor immunity with dendritic cell reprogramming strategies. Reprogramming cancer cells to antigen-presenting cells.
2023) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Clinical insights into small cell lung cancer : Tumor heterogeneity, diagnosis, therapy, and future directions
(
- Contribution to journal › Scientific review
-
Mark
Priorities in Cardio-Oncology Basic and Translational Science : GCOS 2023 Symposium Proceedings: JACC: CardioOncology State-of-the-Art Review
(
- Contribution to journal › Scientific review
-
Mark
Неоадъювантная химиоиммунотерапия у пациентов раком желудка с микросателлитной нестабильностью
(
- Contribution to journal › Article